Course fee
The fee for the programme is as follows:
: £140
Standard mode - 2 months: £90
Postgraduate Certificate in Ketamine for PTSD
Join our program designed for healthcare professionals seeking specialized PTSD treatment training with ketamine therapy. Learn the latest research, protocols, and best practices to effectively address PTSD symptoms. This advanced certificate is ideal for psychologists, psychiatrists, and other mental health practitioners looking to enhance their skills and offer innovative treatments. Gain hands-on experience and valuable insights to make a real difference in the lives of PTSD patients. Take the next step in your career and become a trusted expert in ketamine-assisted therapy.
Start your journey towards becoming a ketamine for PTSD specialist today!
The fee for the programme is as follows:
: £140
Standard mode - 2 months: £90
Our Postgraduate Certificate in Ketamine for PTSD is designed to equip healthcare professionals with specialized knowledge and skills in using ketamine-assisted therapy to treat patients with post-traumatic stress disorder (PTSD). The program focuses on evidence-based practices, ethical considerations, and practical applications in a clinical setting.
Upon completion of this certificate, participants will be able to demonstrate a deep understanding of the pharmacology of ketamine, its effects on the brain, and its therapeutic potential for addressing PTSD symptoms. They will also develop proficiency in assessing patients for ketamine treatment, monitoring treatment outcomes, and ensuring patient safety throughout the process.
The program duration is 6 months, with a flexible, self-paced learning format that allows participants to balance their studies with professional commitments. This structure enables healthcare professionals to acquire specialized knowledge in ketamine therapy without disrupting their current practice or work schedules.
Given the growing interest in alternative treatment modalities for mental health conditions like PTSD, this certificate is highly relevant to current trends in healthcare. Ketamine-assisted therapy has gained recognition for its effectiveness in providing rapid relief to patients with treatment-resistant PTSD, making it a valuable addition to mental healthcare practices.
| Year | Number of PTSD cases |
|---|---|
| 2018 | 25000 |
| 2019 | 28000 |
| 2020 | 32000 |
| 2021 | 35000 |